
"Sector" = median of Healthcare across 84 companies
Thermo Fisher Scientific Inc. is a global leader in serving science, providing a wide range of analytical instruments, laboratory equipment, reagents, consumables, software, and services to customers in the healthcare, pharmaceutical, biotechnology, academic, and industrial sectors. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Its products and services support research, discovery, diagnosis, and production across the life sciences and applied markets.
Thermo Fisher generates revenue primarily from the sale of instruments, consumables, and services. The Laboratory Products and Services segment is the largest revenue contributor, offering laboratory chemicals, consumables, and third-party distribution. The Life Sciences Solutions segment provides reagents and instruments for biological research, while Analytical Instruments focuses on mass spectrometry, chromatography, and electron microscopy. Specialty Diagnostics offers diagnostic test kits and reagents. The company's business model emphasizes recurring revenue from consumables and services, with a strong focus on innovation and customer partnerships.
The company operates in the highly competitive Diagnostics & Research industry within the healthcare sector. Key competitors include Danaher, Agilent, and Bio-Rad Laboratories. Thermo Fisher holds a leading position due to its broad product portfolio, extensive distribution network, and strong brand reputation. Its scale and diversification provide a competitive advantage, allowing it to serve customers across multiple end markets and geographies. The company's focus on high-growth areas such as bioproduction, clinical diagnostics, and applied markets supports its market leadership.
Thermo Fisher's customers include pharmaceutical and biotech companies, hospitals and clinical laboratories, academic and research institutions, and government agencies. Its products are used in drug discovery, clinical diagnostics, environmental analysis, and food safety testing. Geographically, the company has a global presence, with North America accounting for the largest share of revenue, followed by Europe and Asia-Pacific. The company's broad customer base and diversified end markets reduce dependency on any single sector, providing stability and growth opportunities.
An auto-generated descriptive profile based on company data, for informational purposes only.
Thermo Fisher Scientific (TMO) shares fell 1.97% to 532.48 USD as of the latest close, amid mixed sector news. The company received FBI approval for its rapid DNA tool in crime investigations, a positive regulatory milestone. Additionally, Thermo Fisher partnered with Arcturus Therapeutics on a Phase III cystic fibrosis trial, expanding its pipeline. However, broader life sciences sector sentiment remains cautious, with analysts like Bernstein resuming coverage on an improving outlook. The upcoming Q2 earnings report, expected soon, is a key catalyst.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 13, 2026 | $0.47 | Apr 15, 2026 | Quarterly |
| Dec 15, 2025 | $0.43 | Jan 15, 2026 | Quarterly |
| Sep 15, 2025 | $0.43 | Oct 15, 2025 | Quarterly |
| Jun 13, 2025 | $0.43 | Jul 15, 2025 | Quarterly |
| Mar 14, 2025 | $0.43 | Apr 15, 2025 | Quarterly |
| Dec 13, 2024 | $0.39 | Jan 15, 2025 | Quarterly |
| Sep 13, 2024 | $0.39 | Oct 15, 2024 | Quarterly |
| Jun 14, 2024 | $0.39 | Jul 15, 2024 | Quarterly |
| Mar 14, 2024 | $0.39 | Apr 15, 2024 | Quarterly |
| Dec 14, 2023 | $0.35 | Jan 16, 2024 | Quarterly |
| Sep 14, 2023 | $0.35 | Oct 13, 2023 | Quarterly |
| Jun 14, 2023 | $0.35 | Jul 14, 2023 | Quarterly |
| Mar 14, 2023 | $0.35 | Apr 14, 2023 | Quarterly |
| Dec 14, 2022 | $0.30 | Jan 16, 2023 | Quarterly |
| Sep 14, 2022 | $0.30 | Oct 14, 2022 | Quarterly |
| Jun 14, 2022 | $0.30 | Jul 15, 2022 | Quarterly |
| Mar 15, 2022 | $0.30 | Apr 14, 2022 | Quarterly |
| Dec 14, 2021 | $0.26 | Jan 14, 2022 | Quarterly |
| Sep 14, 2021 | $0.26 | Oct 15, 2021 | Quarterly |
| Jun 14, 2021 | $0.26 | Jul 15, 2021 | Quarterly |
| Mar 15, 2021 | $0.26 | Apr 16, 2021 | Quarterly |
| Dec 14, 2020 | $0.22 | Jan 15, 2021 | Quarterly |
| Sep 14, 2020 | $0.22 | Oct 15, 2020 | Quarterly |
| Jun 12, 2020 | $0.22 | Jul 15, 2020 | Quarterly |
Wrqti brings Thermo Fisher Scientific Inc data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Thermo Fisher Scientific Inc:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.